Program Cancer

Against Itself™

What is the Holy Grail in cancer?

Kill the bad cells, but don't kill the good cells

"Malignant growth and normal growth are so genetically intertwined that unbraiding the two might be one of the most significant scientific challenges faced by our species."
Prologue in The Emperor Of All Maladies
Pulitzer Prize 2011, Siddhartha Mukherjee

Earli uses AI to build the first genetic switches that program only cancer cells to make their own therapies.

News

TEDx Palo Alto: Programming Cancer With AI To Self-Destruct

TBPN - Earli announces next $44M in funding

NPR BioTech Nation - Podcast: Can Cancer Cells Be Turned Against Themselves? Cyriac Roeding & Dr. David Suhy

TIME: Op-Ed: How AI Can Beat Cancer

White House Cancer Moonshot: Earli highlighted as a key initiative

S. Korea #1 Business Newspaper Maeil: Ordering Cancer Cells to "Self-Destruct"? U.S. Biotech Firm Unveils Breakthrough Gene Technology

The Scientist - Interview: Turning Tumors Against Themselves From the Inside

BiotechTV: How Earli AI-designed Genetic Switches That Turn On Only in Cancer

Fast Company: A Cancer Genius Died From Cancer. His Startup is Getting Revenge

Genetic Engineering & Biotechnology News: Earli Detection: “Synthetic” Biomarkers Light Up Hidden...

Drug Discovery Trends: Earli and Accenture Partner in Quest to Turn Cancer Against Itself

Biospace - Opinion: Trump Must Make Biotech Innovations a National Priority

Newsweek: One Glaring Problem in the U.S. Plan to Reduce Cancer Deaths | Opinion

CGT Live: Using DNA Nanoplasmids as a Diagnostic Tool in Cancer

Tech Target: Using Synthetic Biomarkers for Early Cancer Detection